These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26812802)

  • 1. Spontaneous conception following GnRHa and progestogen therapy in adenomyosis.
    Dasrilsyah RA; Shan LP; Kwang NB; Shafiee MN; Omar MH
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):77-9. PubMed ID: 26812802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dydrogesterone use in early pregnancy.
    Mirza FG; Patki A; Pexman-Fieth C
    Gynecol Endocrinol; 2016; 32(2):97-106. PubMed ID: 26800266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of medical therapy in the management of uterine adenomyosis.
    Vannuccini S; Luisi S; Tosti C; Sorbi F; Petraglia F
    Fertil Steril; 2018 Mar; 109(3):398-405. PubMed ID: 29566852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Current Understanding of Molecular Mechanisms in Adenomyosis-Associated Infertility and the Treatment Strategy for Assisted Reproductive Technology.
    Wu HM; Tsai TC; Liu SM; Pai AH; Chen LH
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elasticity of adenomyosis is increased after GnRHa therapy and is associated with spontaneous pregnancy in infertile patents.
    Xie M; Yu H; Zhang X; Wang W; Ren Y
    J Gynecol Obstet Hum Reprod; 2019 Dec; 48(10):849-853. PubMed ID: 31067498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine adenomyosis and infertility, review of reproductive outcome after in vitro fertilization and surgery.
    Dueholm M
    Acta Obstet Gynecol Scand; 2017 Jun; 96(6):715-726. PubMed ID: 28556124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study.
    Ghosh S; Chattopadhyay R; Goswami S; Chaudhury K; Chakravarty B; Ganesh A
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy after medical therapy of adenomyosis with a gonadotropin-releasing hormone agonist.
    Hirata JD; Moghissi KS; Ginsburg KA
    Fertil Steril; 1993 Feb; 59(2):444-5. PubMed ID: 8425644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on the pharmacological management of adenomyosis.
    Streuli I; Dubuisson J; Santulli P; de Ziegler D; Batteux F; Chapron C
    Expert Opin Pharmacother; 2014 Nov; 15(16):2347-60. PubMed ID: 25196637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders.
    Griffin D; Benadiva C; Kummer N; Budinetz T; Nulsen J; Engmann L
    Fertil Steril; 2012 Jun; 97(6):1316-20. PubMed ID: 22480822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical observations on luteal phase inadequacy.
    Taubert HD; Jürgensen O; Becker H
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):586-94. PubMed ID: 4101703
    [No Abstract]   [Full Text] [Related]  

  • 12. The Effect of Uterine Adenomyosis on IVF Outcomes: a Systematic Review and Meta-analysis.
    Cozzolino M; Tartaglia S; Pellegrini L; Troiano G; Rizzo G; Petraglia F
    Reprod Sci; 2022 Nov; 29(11):3177-3193. PubMed ID: 34981458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors.
    Blumenfeld Z; Zur H; Dann EJ
    Oncologist; 2015 Nov; 20(11):1283-9. PubMed ID: 26463871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenomyosis and fertility outcomes.
    Yoldemir T
    Gynecol Endocrinol; 2020 Jun; 36(6):473-474. PubMed ID: 32648499
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis.
    Niu Z; Chen Q; Sun Y; Feng Y
    Gynecol Endocrinol; 2013 Dec; 29(12):1026-30. PubMed ID: 24006906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy rate in endometriosis patients according to the severity of the disease after using a combined approach of laparoscopy, GnRH agonist treatment and in vitro fertilization.
    Sõritsa D; Saare M; Laisk-Podar T; Peters M; Sõritsa A; Matt K; Karro H; Salumets A
    Gynecol Obstet Invest; 2015; 79(1):34-9. PubMed ID: 25277802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome analysis of eutopic endometrium in adenomyosis after GnRH agonist treatment.
    Tian J; Kang N; Wang J; Sun H; Yan G; Huang C; Mei J
    Reprod Biol Endocrinol; 2022 Jan; 20(1):13. PubMed ID: 35022045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility outcome of infertile women with adenomyosis treated with the combination of a conservative microsurgical technique and GnRH agonist: long-term follow-up in a series of nine patients.
    Huang BS; Seow KM; Tsui KH; Huang CY; Lu YF; Wang PH
    Taiwan J Obstet Gynecol; 2012 Jun; 51(2):212-6. PubMed ID: 22795096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An update on adenomyosis and implantation].
    Yazbeck C; Falcone S; Ballout A; Gauché-Cazalis C; Epelboin S; Patrat C; Luton D
    Gynecol Obstet Fertil; 2015 Oct; 43(10):665-9. PubMed ID: 26439871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review on role of progestogen (dydrogesterone) in the prevention of gestational hypertension.
    Mohamad Razi ZR; Schindler AE
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):73-6. PubMed ID: 27101553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.